Press releases

Génome Québec invests time and money to make sure that genomics becomes a powerful economic force and delivers innovative solutions in health and the environment. In this section, you will find all the latest press releases published by Génome Québec.

1 2 > >>

$3M to accelerate the integration of genomics into clinical practice

Montréal, December 14, 2020 – Génome Québec, in partnership with Genome Canada, is pleased to announce that two CARTaGENE scientific directors, Guillaume Lettre, PhD and Simon Gravel, PhD, have been awarded funding of more than $3 million for the GenoRef-Q Initiative. This initiative will sequence (...)

Published on Monday December 14, 2020

$1.5 million to support cancer research by leveraging data!

Early this year, Génome Québec, Oncopole and IVADO joined forces to launch the “Omics Data Against Cancer” (ODAC) competition.

Published on Thursday November 5, 2020

Genomics solutions for health, agriculture, agrifood and the environment in Québec

Montréal, October 26, 2020 — Génome Québec is proud to announce that four Québec-based research teams have received major funding in agriculture, agrifood, health and the environment. A sum of close to $8 million was received for research projects under Genome Canada’s Genomic Applications Partners (...)

Published on Monday October 26, 2020

Génome Québec announces the appointment of its new Vice President, Scientific Affairs

Montréal, October 6, 2020 — Daniel Coderre, President and CEO of Génome Québec, is happy to announce the appointment of Stéphanie Lord-Fontaine, PhD as Vice President, Scientific Affairs. The decision was unanimously endorsed by the Board of Directors on September 23, 2020. Ms. Lord-Fontaine will (...)

Published on Tuesday October 6, 2020

Race for the discovery of COVID-19 medications

Montreal, June 17, 2020 — Génome Québec, in partnership with IRIC, Université de Montréal, MILA and McMaster University, is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications. Spearheaded by professors Michael Tyers (IRIC/Univ (...)

Published on Wednesday June 17, 2020

1 2 > >>